About Hemostasis Valves
Hemostasis is the physiological process that helps to maintain blood in the fluid state and prevent the loss of blood from damaged blood vessels through clot formation. Many coagulation proteins are involved in the reactions that participate in the hemostatic process. Deficiencies in any of the coagulation proteins may lead to bleeding. Hemostasis valves are used in interventional and diagnostic procedures for sealing off and minimizing fluid loss. It works by reducing the opening time during wire or microcatheter insertion.
Attributes | Details |
---|
Study Period | 2018-2030 |
Base Year | 2023 |
Unit | Value (USD Million) |
CAGR | 5.8% |
The hemostasis valve market is expected to grow in the coming years, driven by the increasing demand for minimally invasive procedures and the growing geriatric population. As the population ages, the demand for procedures such as angioplasty and angiography is expected to increase. This is because these procedures are less invasive than traditional surgery and are therefore better suited for older patients. Analyst at AMA Research estimates that United States Players will contribute the maximum growth to Global Hemostasis Valves market throughout the forecasted period. Established and emerging Players should take a closer view at their existing organizations and reinvent traditional business and operating models to adapt to the future.
Medtronic, Inc. (Ireland), Boston Scientific (United States), Abbott (United States), Teleflex Incorporated (United States), B. Braun Melsungen (Germany), DeRoyal Industries, Inc. (United States), Argon Medical (United States), Freudenberg Medical (United States), Scitech (Brazil) and Merit Medical Systems, Inc. (United States) are some of the key players that are part of study coverage. Additionally, the Players which are also part of the research coverage are Terumo Corporation (Japan), Shenzhen Antmed Co.,Ltd. (China) and VascuTech Medical LLC (United States).
Segmentation Overview
AMA Research has segmented the market of Global Hemostasis Valves market by Type (One-Handed Hemostasis Valve, Hemostasis Valve Y-Connectors, Double Y-Connector Hemostasis Valves and Other), Application (Angiography and Angioplasty) and Region.
On the basis of geography, the market of Hemostasis Valves has been segmented into South America (Brazil, Argentina, Rest of South America), Asia Pacific (China, Japan, India, South Korea, Taiwan, Australia, Rest of Asia-Pacific), Europe (Germany, France, Italy, United Kingdom, Netherlands, Rest of Europe), MEA (Middle East, Africa), North America (United States, Canada, Mexico). If we see Market by End-user, the sub-segment i.e. Hospitals will boost the Hemostasis Valves market. Additionally, the rising demand from SMEs and various industry verticals gives enough cushion to market growth.
Influencing Trend:
Trend for Innovative Medical Devices
Market Growth Drivers:
Increased Number of Angiography and Angioplasty Procedures Worldwide, Availabilities of Health Care Facilities and Rising Geriatric Population
Challenges:
Lack of Availabilities of Advanced Healthcare Facilities in Developing Countries
Restraints:
Risk of Air Leakage That May Cause an Air Embolism
Opportunities:
Rising Prevalence to Coronary Artery Disease and Increasing Number of Hospitals Worldwide With Advanced Facilities
Market Leaders and their expansionary development strategies
On April 25, 2022: Acquired Phadia. Thermo Fisher Scientific Announces Completion of Acquisition of Phadia, Thermo Fisher Scientific announced the completion of its acquisition of Phadia. This information aligns with the previous query about Hemostasis Diagnostics
On January 10, 2023, Werfen launched a drug of Hemostasis Diagnostics where Werfen merges with Instrumentation Laboratory. This involved a branding change, not a merger. Werfen continued to operate as a single entity after this date.
Key Target Audience
Hemostasis Valves Manufacturers, Raw Material Suppliers/ Buyers, Distributors, Government Body & Associations and End-user
About Approach
To evaluate and validate the market size various sources including primary and secondary analysis is utilized. AMA Research follows regulatory standards such as NAICS/SIC/ICB/TRCB, to have a better understanding of the market. The market study is conducted on basis of more than 200 companies dealing in the market regional as well as global areas with the purpose to understand the companies positioning regarding the market value, volume, and their market share for regional as well as global.
Further to bring relevance specific to any niche market we set and apply a number of criteria like Geographic Footprints, Regional Segments of Revenue, Operational Centres, etc. The next step is to finalize a team (In-House + Data Agencies) who then starts collecting C & D level executives and profiles, Industry experts, Opinion leaders, etc., and work towards appointment generation.
The primary research is performed by taking the interviews of executives of various companies dealing in the market as well as using the survey reports, research institute, and latest research reports. Meanwhile, the analyst team keeps preparing a set of questionnaires, and after getting the appointee list; the target audience is then tapped and segregated with various mediums and channels that are feasible for making connections that including email communication, telephonic, skype, LinkedIn Group & InMail, Community Forums, Community Forums, open Survey, SurveyMonkey, etc.